e-learning
resources
Berlin 2001
Monday 24.09.2001
Assessment and monitoring of inflammation in COPD and asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Are bronchial hyperresponsiveness and exhaled nitric oxide related in asthma? Effects of fluticasone
M. L. Nieto, A. De Diego, M. Perpina, L. Compte, V. Macian (Valencia, Spain)
Source:
Annual Congress 2001 - Assessment and monitoring of inflammation in COPD and asthma
Session:
Assessment and monitoring of inflammation in COPD and asthma
Session type:
Poster Discussion
Number:
2224
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. L. Nieto, A. De Diego, M. Perpina, L. Compte, V. Macian (Valencia, Spain). Are bronchial hyperresponsiveness and exhaled nitric oxide related in asthma? Effects of fluticasone. Eur Respir J 2001; 16: Suppl. 31, 2224
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Relationship between exhaled nitric oxide and bronchial hyperreactivity in adult with asthma
Source: Annual Congress 2009 - Airway hyperresponsiveness: mechanism and assessment
Year: 2009
The relationship between exhaled nitric oxide and airway hyperresponsiveness in patients with asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 366s
Year: 2007
Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children
Source: Eur Respir J 2002; 20: 630-634
Year: 2002
Exhaled nitric oxide and bronchial hyperresponsiveness in steroid-naive patients with asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 49s
Year: 2002
The relationship between exhaled nitric oxide, bronchial hyperresponsiveness and exercise-induced bronchospasm in Japanese children with asthma
Source: Annual Congress 2010 - Phenotypes, mechanisms and diagnosis of asthma in childhood
Year: 2010
The relationship between exhaled nitric oxide and compliance/adherence in patients with bronchial asthma using inhaled corticosteroids
Source: Annual Congress 2012 - Clinical and diagnostic markers and management of paediatric allergic diseases
Year: 2012
Relation of asthma control and exhaled nitric oxide in patients with bronchial hyperresponsiveness to methacholine
Source: Annual Congress 2013 –New issues in lung function testing
Year: 2013
Methacholine airway hyperresponsiveness is associated with fraction of nitric oxide irrespective of asthma
Source: Annual Congress 2012 - Mechanisms and risk of childhood asthma and allergy
Year: 2012
Exhaled nitric oxide as predictor of bronchial hyperresponsiveness to methacholine in subjects with respiratory symptoms
Source: International Congress 2017 – Biomarker-based asthma control
Year: 2017
Effect of montelukast treatment and withdrawal on exhaled nitric oxide and lung function in atopic asthmatic children
Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma
Year: 2007
Domiciliary exhaled nitric oxide and eosinophilic airway inflammation in adults with asthma
Source: Eur Respir J 2016; 48: 242-244
Year: 2016
Inhaled fluticasone decreases bronchial but not alveolar nitric oxide output in asthma
Source: Eur Respir J 2001; 18: 635-639
Year: 2001
Increased exhaled nitric oxide (E-NO) in asthmatics with bronchial hyperreactivity to MCh and UNDW
Source: Eur Respir J 2001; 18: Suppl. 33, 164s
Year: 2001
Similar levels of nitric oxide in exhaled air in asthma and rhinitis after bronchial allergen challenge
Source: Eur Respir J 2001; 18: Suppl. 33, 269s
Year: 2001
Exhaled nitric oxide and lower airway involvement in persistent rhinitis
Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers
vs
induced sputum
Year: 2006
Montelukast versus fluticasone: effects on lung function, airway responsiveness and inflammation in moderate asthma
Source: Eur Respir J 2002; 20: 853-858
Year: 2002
Bronchial nitric oxide output predicts responsiveness to inhaled steroids in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 429s
Year: 2004
Effect of adding montelukast to budesonide treatment on exhaled nitric oxide in mild to moderate asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 259s
Year: 2004
Exhaled nitric oxide during infancy as a risk factor for asthma and airway hyperreactivity
Source: Eur Respir J 2015; 45: 98-106
Year: 2015
Exhaled nitric oxide and bronchial hyperresponsiveness in patients with cough variant asthma or new-onset classic mild asthma
Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept